CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 2
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 2
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti ORF particles, MIA2 (Myc-DDK tagged) - Human melanoma inhibitory activity 2 (MIA2), 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK |
Tag | Myc-DDK |
Lenti ORF particles, MIA2 (mGFP-tagged) - Human melanoma inhibitory activity 2 (MIA2), 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP |
Tag | mGFP |
CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
MIA2 (Myc-DDK-tagged)-Human melanoma inhibitory activity 2 (MIA2)
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
MIA2 (GFP-tagged) - Human melanoma inhibitory activity 2 (MIA2)
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 4
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti-ORF clone of CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 4
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
USD 1,010.00
7 Weeks
Lenti ORF particles, CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 4, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 4
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
USD 1,010.00
7 Weeks
Lenti ORF particles, CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 4, 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
USD 1,290.00
6 Weeks
Lenti ORF particles, CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
USD 1,290.00
6 Weeks
Lenti ORF particles, CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1, 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 3
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
Lenti-ORF clone of CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 3
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
USD 1,250.00
7 Weeks
Lenti ORF particles, CTAGE5 (Myc-DDK-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 3, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 3
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
USD 1,250.00
7 Weeks
Lenti ORF particles, CTAGE5 (mGFP-tagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 3, 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human melanoma inhibitory activity 2 (MIA2), Myc-DDK-tagged
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, MIA2 (Myc-DDK tagged) - Human melanoma inhibitory activity 2 (MIA2), 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human melanoma inhibitory activity 2 (MIA2), mGFP tagged
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
Lenti ORF particles, MIA2 (mGFP-tagged) - Human melanoma inhibitory activity 2 (MIA2), 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human CTAGE family, member 5 (CTAGE5), transcript variant 2, Myc-DDK-tagged
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
USD 1,280.00
6 Weeks
Lenti ORF particles, CTAGE5 (Myc-DDK tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 2, 200ul, >10^7 TU/mL
Vector | pLenti-C-Myc-DDK-P2A-Puro |
Tag | Myc-DDK |
Mammalian Cell Selection | Puromycin |
Lenti ORF clone of Human CTAGE family, member 5 (CTAGE5), transcript variant 2, mGFP tagged
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
USD 1,280.00
6 Weeks
Lenti ORF particles, CTAGE5 (mGFP-tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 2, 200ul, >10^7 TU/mL
Vector | pLenti-C-mGFP-P2A-Puro |
Tag | mGFP |
Mammalian Cell Selection | Puromycin |
CTAGE5 (Myc-DDK tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 7
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
CTAGE5 (Myc-DDK tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 5
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
CTAGE5 (Myc-DDK tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 6
Vector | pCMV6-Entry |
Tag | Myc-DDK |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 4
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 1
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 3
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Human CTAGE family, member 5 (CTAGE5), transcript variant 2
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 7
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 5
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
CTAGE5 (GFP-tagged) - Homo sapiens CTAGE family, member 5 (CTAGE5), transcript variant 6
Vector | pCMV6-AC-GFP |
Tag | TurboGFP |
Mammalian Cell Selection | Neomycin |
Lenti ORF clone of Human melanoma inhibitory activity 2 (MIA2), Myc-DDK-tagged
Vector | pLenti-C-Myc-DDK |
Tag | Myc-DDK |
Mammalian Cell Selection | None |
Rabbit Polyclonal Anti-CTAGE5 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-CTAGE5 antibody: synthetic peptide directed towards the middle region of human CTAGE5. Synthetic peptide located within the following region: LLEGPLRLSPLLPGGGGRGSRGPGNPLDHQITNERGESSCDRLTDPHRAP |
Rabbit Polyclonal Anti-CTAGE5 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-CTAGE5 antibody: synthetic peptide directed towards the N terminal of human CTAGE5. Synthetic peptide located within the following region: DEILCLEKELKEEKSKHSEQDELMADISKRIQSLEDESKSLKSQVAEAKM |
Rabbit Polyclonal Anti-CTAGE5 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-CTAGE5 antibody: synthetic peptide directed towards the middle region of human CTAGE5. Synthetic peptide located within the following region: PPRGFPPYLPPRPGFFPPPPHSEGRSEFPSGLIPPSNEPATEHPEPQQET |
Rabbit Polyclonal Anti-CTAGE5 Antibody
Applications | WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | The immunogen for anti-CTAGE5 antibody: synthetic peptide directed towards the middle region of human CTAGE5. Synthetic peptide located within the following region: KLSKVDEKISHATEELETYRKRAKDLEEELERTIHSYQGQIISHEKKAHD |
Lenti ORF clone of Human melanoma inhibitory activity 2 (MIA2), mGFP tagged
Vector | pLenti-C-mGFP |
Tag | mGFP |
Mammalian Cell Selection | None |
CTAGE5 (untagged)-Human CTAGE family, member 5 (CTAGE5), transcript variant 1
Vector | pCMV6-XL5 |
Tag | Tag Free |
Mammalian Cell Selection | None |
Rabbit polyclonal anti-MIA2 antibody
Applications | WB |
Reactivities | Human |
Immunogen | The antiserum was produced against synthesized peptide derived from internal of human MIA2. |
Anti-Human MIA-2 Rabbit Polyclonal Antibody
Applications | ELISA, IHC, WB |
Reactivities | Human |
Immunogen | E.coli derived Recombinant Human MIA-2 |
CTAGE5 (MIA2) (C-term) rabbit polyclonal antibody, Aff - Purified
Applications | IHC, WB |
Reactivities | Human |
Conjugation | Unconjugated |
Immunogen | KLH conjugated synthetic peptide between 774-804 amino acids from the C-terminal region of human CTAGE5 |
Biotinylated Anti-Human MIA-2 Rabbit Polyclonal Antibody
Applications | ELISA |
Reactivities | Human |
Immunogen | E.coli derived Recombinant Human MIA-2 |
Rabbit Polyclonal Anti-MIA2 Antibody
Applications | WB |
Reactivities | Human |
Immunogen | The immunogen for anti-MIA2 antibody: synthetic peptide directed towards the C terminal of human MIA2. Synthetic peptide located within the following region: NTKVMIFKSSYSLSDMVSNIELPTRIHEEVYFEPSSSKDSDENSKPSVDT |